Men's Health Month
Featured
DNA Repair Defects as Therapeutic Targets in Metastatic Prostate CancerDr. Arpit Rao discusses synthetic lethality as a treatment mechanism for prostate cancer, indications for PARP inhibitor therapies, clinical trials involving novel PARP inhibitors, and how to deliver high quality care after these drugs have been integrated into routine clinical practice.